1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Rheumatoid Arthritis Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drugs for Rheumatoid Arthritis by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drugs for Rheumatoid Arthritis by Country/Region, 2017, 2022 & 2028
2.2 Drugs for Rheumatoid Arthritis Segment by Type
2.2.1 Prescription Drugs for Rheumatoid Arthritis
2.2.2 OTC Drugs for Rheumatoid Arthritis
2.3 Drugs for Rheumatoid Arthritis Sales by Type
2.3.1 Global Drugs for Rheumatoid Arthritis Sales Market Share by Type (2017-2022)
2.3.2 Global Drugs for Rheumatoid Arthritis Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drugs for Rheumatoid Arthritis Sale Price by Type (2017-2022)
2.4 Drugs for Rheumatoid Arthritis Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Drugs for Rheumatoid Arthritis Sales by Application
2.5.1 Global Drugs for Rheumatoid Arthritis Sale Market Share by Application (2017-2022)
2.5.2 Global Drugs for Rheumatoid Arthritis Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drugs for Rheumatoid Arthritis Sale Price by Application (2017-2022)
3 Global Drugs for Rheumatoid Arthritis by Company
3.1 Global Drugs for Rheumatoid Arthritis Breakdown Data by Company
3.1.1 Global Drugs for Rheumatoid Arthritis Annual Sales by Company (2020-2022)
3.1.2 Global Drugs for Rheumatoid Arthritis Sales Market Share by Company (2020-2022)
3.2 Global Drugs for Rheumatoid Arthritis Annual Revenue by Company (2020-2022)
3.2.1 Global Drugs for Rheumatoid Arthritis Revenue by Company (2020-2022)
3.2.2 Global Drugs for Rheumatoid Arthritis Revenue Market Share by Company (2020-2022)
3.3 Global Drugs for Rheumatoid Arthritis Sale Price by Company
3.4 Key Manufacturers Drugs for Rheumatoid Arthritis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for Rheumatoid Arthritis Product Location Distribution
3.4.2 Players Drugs for Rheumatoid Arthritis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drugs for Rheumatoid Arthritis by Geographic Region
4.1 World Historic Drugs for Rheumatoid Arthritis Market Size by Geographic Region (2017-2022)
4.1.1 Global Drugs for Rheumatoid Arthritis Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drugs for Rheumatoid Arthritis Annual Revenue by Geographic Region
4.2 World Historic Drugs for Rheumatoid Arthritis Market Size by Country/Region (2017-2022)
4.2.1 Global Drugs for Rheumatoid Arthritis Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drugs for Rheumatoid Arthritis Annual Revenue by Country/Region
4.3 Americas Drugs for Rheumatoid Arthritis Sales Growth
4.4 APAC Drugs for Rheumatoid Arthritis Sales Growth
4.5 Europe Drugs for Rheumatoid Arthritis Sales Growth
4.6 Middle East & Africa Drugs for Rheumatoid Arthritis Sales Growth
5 Americas
5.1 Americas Drugs for Rheumatoid Arthritis Sales by Country
5.1.1 Americas Drugs for Rheumatoid Arthritis Sales by Country (2017-2022)
5.1.2 Americas Drugs for Rheumatoid Arthritis Revenue by Country (2017-2022)
5.2 Americas Drugs for Rheumatoid Arthritis Sales by Type
5.3 Americas Drugs for Rheumatoid Arthritis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Rheumatoid Arthritis Sales by Region
6.1.1 APAC Drugs for Rheumatoid Arthritis Sales by Region (2017-2022)
6.1.2 APAC Drugs for Rheumatoid Arthritis Revenue by Region (2017-2022)
6.2 APAC Drugs for Rheumatoid Arthritis Sales by Type
6.3 APAC Drugs for Rheumatoid Arthritis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drugs for Rheumatoid Arthritis by Country
7.1.1 Europe Drugs for Rheumatoid Arthritis Sales by Country (2017-2022)
7.1.2 Europe Drugs for Rheumatoid Arthritis Revenue by Country (2017-2022)
7.2 Europe Drugs for Rheumatoid Arthritis Sales by Type
7.3 Europe Drugs for Rheumatoid Arthritis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Rheumatoid Arthritis by Country
8.1.1 Middle East & Africa Drugs for Rheumatoid Arthritis Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drugs for Rheumatoid Arthritis Revenue by Country (2017-2022)
8.2 Middle East & Africa Drugs for Rheumatoid Arthritis Sales by Type
8.3 Middle East & Africa Drugs for Rheumatoid Arthritis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for Rheumatoid Arthritis
10.3 Manufacturing Process Analysis of Drugs for Rheumatoid Arthritis
10.4 Industry Chain Structure of Drugs for Rheumatoid Arthritis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drugs for Rheumatoid Arthritis Distributors
11.3 Drugs for Rheumatoid Arthritis Customer
12 World Forecast Review for Drugs for Rheumatoid Arthritis by Geographic Region
12.1 Global Drugs for Rheumatoid Arthritis Market Size Forecast by Region
12.1.1 Global Drugs for Rheumatoid Arthritis Forecast by Region (2023-2028)
12.1.2 Global Drugs for Rheumatoid Arthritis Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drugs for Rheumatoid Arthritis Forecast by Type
12.7 Global Drugs for Rheumatoid Arthritis Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Information
13.1.2 AbbVie Inc Drugs for Rheumatoid Arthritis Product Offered
13.1.3 AbbVie Inc Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Inc Main Business Overview
13.1.5 AbbVie Inc Latest Developments
13.2 Hoffman-La Roche AG
13.2.1 Hoffman-La Roche AG Company Information
13.2.2 Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Product Offered
13.2.3 Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hoffman-La Roche AG Main Business Overview
13.2.5 Hoffman-La Roche AG Latest Developments
13.3 Amgen Inc
13.3.1 Amgen Inc Company Information
13.3.2 Amgen Inc Drugs for Rheumatoid Arthritis Product Offered
13.3.3 Amgen Inc Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Amgen Inc Main Business Overview
13.3.5 Amgen Inc Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Drugs for Rheumatoid Arthritis Product Offered
13.4.3 Pfizer Inc Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Bristol-Myers Squibb Co
13.5.1 Bristol-Myers Squibb Co Company Information
13.5.2 Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Product Offered
13.5.3 Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bristol-Myers Squibb Co Main Business Overview
13.5.5 Bristol-Myers Squibb Co Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Drugs for Rheumatoid Arthritis Product Offered
13.6.3 Johnson & Johnson Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 UCB Biosciences Inc
13.7.1 UCB Biosciences Inc Company Information
13.7.2 UCB Biosciences Inc Drugs for Rheumatoid Arthritis Product Offered
13.7.3 UCB Biosciences Inc Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 UCB Biosciences Inc Main Business Overview
13.7.5 UCB Biosciences Inc Latest Developments
13.8 Mitsubishi Tanabe Pharma Corp
13.8.1 Mitsubishi Tanabe Pharma Corp Company Information
13.8.2 Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Product Offered
13.8.3 Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mitsubishi Tanabe Pharma Corp Main Business Overview
13.8.5 Mitsubishi Tanabe Pharma Corp Latest Developments
13.9 Biogen Inc
13.9.1 Biogen Inc Company Information
13.9.2 Biogen Inc Drugs for Rheumatoid Arthritis Product Offered
13.9.3 Biogen Inc Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Biogen Inc Main Business Overview
13.9.5 Biogen Inc Latest Developments
13.10 Merck & Co
13.10.1 Merck & Co Company Information
13.10.2 Merck & Co Drugs for Rheumatoid Arthritis Product Offered
13.10.3 Merck & Co Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Merck & Co Main Business Overview
13.10.5 Merck & Co Latest Developments
13.11 Market Segment by Product Type
13.11.1 Market Segment by Product Type Company Information
13.11.2 Market Segment by Product Type Drugs for Rheumatoid Arthritis Product Offered
13.11.3 Market Segment by Product Type Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Market Segment by Product Type Main Business Overview
13.11.5 Market Segment by Product Type Latest Developments
13.12 Pharmaceuticals
13.12.1 Pharmaceuticals Company Information
13.12.2 Pharmaceuticals Drugs for Rheumatoid Arthritis Product Offered
13.12.3 Pharmaceuticals Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Pharmaceuticals Main Business Overview
13.12.5 Pharmaceuticals Latest Developments
13.13 Biopharmaceuticals
13.13.1 Biopharmaceuticals Company Information
13.13.2 Biopharmaceuticals Drugs for Rheumatoid Arthritis Product Offered
13.13.3 Biopharmaceuticals Drugs for Rheumatoid Arthritis Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Biopharmaceuticals Main Business Overview
13.13.5 Biopharmaceuticals Latest Developments
14 Research Findings and Conclusion
【掲載企業】
AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Co、 Market Segment by Product Type、 Pharmaceuticals、 Biopharmaceuticals